van der Graaf WTA - Search Results

1

Lesion detection by [⁸⁹Zr]Zr-DFO-girentuximab and [¹⁸F]FDG-PET/CT in patients with newly diagnosed metastatic renal cell carcinoma.

Verhoeff SR, van Es SC, Boon E, van Helden E, Angus L, Elias SG, Oosting SF, Aarntzen EH, Brouwers AH, Kwee TC, Heskamp S, Hoekstra OS, Verheul H, van der Veldt AAM, de Vries EGE, Boerman OC, van der Graaf WTA, Oyen WJG, van Herpen CML. Verhoeff SR, et al. Among authors: van helden e, van der veldt aam, van der graaf wta, van herpen cml, van es sc. Eur J Nucl Med Mol Imaging. 2019 Aug;46(9):1931-1939. doi: 10.1007/s00259-019-04358-9. Epub 2019 Jun 6. Eur J Nucl Med Mol Imaging. 2019. PMID: 31172212 Free PMC article. Clinical Trial.

2

In vitro and in vivo modulation of multi-drug resistance with amiodarone.

van der Graaf WT, de Vries EG, Uges DR, Nanninga AG, Meijer C, Vellenga E, Mulder PO, Mulder NH. van der Graaf WT, et al. Int J Cancer. 1991 Jun 19;48(4):616-22. doi: 10.1002/ijc.2910480422. Int J Cancer. 1991. PMID: 1646180

3

Mitoxantrone: bluebeard for malignancies.

van der Graaf WT, de Vries EG. van der Graaf WT, et al. Anticancer Drugs. 1990 Dec;1(2):109-25. Anticancer Drugs. 1990. PMID: 2151849

4

Dose escalation of dacarbazine combined with interferon alpha-2a, G-CSF and ondansetron in patients with metastatic melanoma.

Buter J, Sleijfer DT, Willemse PH, van der Graaf WT, de Vries EG, Schraffordt Koops H, Mulder NH. Buter J, et al. Anticancer Res. 1994 May-Jun;14(3B):1325-8. Anticancer Res. 1994. PMID: 7520681 Clinical Trial.

5

Dacarbazine (DTIC)-based chemotherapy or chemoimmunotherapy of patients with disseminated malignant melanoma.

Mulder NH, van der Graaf WT, Willemse PH, Koops HS, de Vries EG, Sleijfer DT. Mulder NH, et al. Br J Cancer. 1994 Oct;70(4):681-3. doi: 10.1038/bjc.1994.372. Br J Cancer. 1994. PMID: 7522510 Free PMC article. Clinical Trial.

6

High-dose methotrexate, vincristine and cisplatin as salvage treatment for relapsed non-seminomatous germ-cell cancer.

Sleijfer S, Van der Graaf WT, Willemse PH, De Vries EG, Schraffordt Koops H, Mulder NH. Sleijfer S, et al. Anticancer Res. 1995 May-Jun;15(3):1039-42. Anticancer Res. 1995. PMID: 7544087 Clinical Trial.

7

Serotonin metabolism following platinum-based chemotherapy combined with the serotonin type-3 antagonist tropisetron.

Schröder CP, van der Graaf WT, Kema IP, Groenewegen A, Sleijfer DT, de Vries EG. Schröder CP, et al. Cancer Chemother Pharmacol. 1995;36(6):477-82. doi: 10.1007/BF00685797. Cancer Chemother Pharmacol. 1995. PMID: 7554039

8

Phase II study of intraperitoneal cisplatin plus systemic etoposide as second-line treatment in patients with small volume residual ovarian cancer.

de Jong RS, Willemse PH, Boonstra H, de Vries EG, van der Graaf WT, Sleijfer DT, van der Zee AG, Mulder NH. de Jong RS, et al. Eur J Cancer. 1995;31A(5):709-13. doi: 10.1016/0959-8049(94)00516-8. Eur J Cancer. 1995. PMID: 7640042 Clinical Trial.

9

Long-term results of induction- and intensification chemotherapy supported with autologous bone marrow reinfusion in patients with disseminated or T4 breast cancer.

Mulder NH, Dolsma WV, Mulder PO, De Vries EG, Willemse PH, Sleijfer DT, Hospers GA, Van der Graaf WT. Mulder NH, et al. Anticancer Res. 1995 Jul-Aug;15(4):1565-8. Anticancer Res. 1995. PMID: 7654046 Clinical Trial.

10

In vitro and in vivo studies on the action of BW502U83, an arylmethylaminopropanediol.

van der Graaf WT, Zijlstra JG, de Vries EG, Nethersell AB, Mulder NH. van der Graaf WT, et al. Anticancer Drugs. 1995 Feb;6(1):34-9. doi: 10.1097/00001813-199502000-00003. Anticancer Drugs. 1995. PMID: 7756681 Clinical Trial.

Save citations to file

Email citations

Send citations to clipboard

Add to Collections

Add to My Bibliography

Create a file for external citation management software

Your saved search

Your RSS Feed

My Custom Filters

Publication date

Text availability

Article attribute

Article type

Article Language

Species

Sex

Age

Other

635 results

Search Page

Filters